Tenax Therapeutics宣布2500万美元私募

• Tenax Therapeutics (NASDAQ:TENX) has entered into a securities purchase agreement for a private placement financing with RTW Investments, with total gross proceeds expected to be ~$25M.
• The private placement will be for an aggregate of 378,346 shares of the common stock and pre-funded warrants to purchase an aggregate of 3.76M shares of common stock.
• The purchase price for each share of common stock is $6.04.
• The pre-funded warrants are exercisable at any time after their original issuance and will not expire.
• The private placement is expected to close on March 5, 2025.
• TENX intends to use the net proceeds from the private placement to advance ongoing and planned Phase 3 clinical trials, as well as for working capital, capital expenditures, and other general corporate purposes.
• TENX shares rise 10% premarket on Wednesday.
• Source: Press release

More on Tenax Therapeutics

• Seeking Alpha’s Quant Rating on Tenax Therapeutics
• Historical earnings data for Tenax Therapeutics
• Financial information for Tenax Therapeutics